Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cowden syndrome.

Shanna Gustafson1, Kevin M Zbuk, Cheryl Scacheri

  • 1Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Seminars in Oncology
|October 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors.

Endocrine-related cancer·2023
Same author

A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.

Annals of surgical oncology·2023
Same author

Development of webcam-collected and artificial-intelligence-derived social and cognitive performance measures for neurodevelopmental genetic syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics·2023
Same author

Hemizygous variants in protein phosphatase 1 regulatory subunit 3F (PPP1R3F) are associated with a neurodevelopmental disorder characterized by developmental delay, intellectual disability and autistic features.

Human molecular genetics·2023
Same author

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.

Breast cancer research and treatment·2023
Same author

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome.

NPJ genomic medicine·2023
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Cowden syndrome (CS) and related PTEN hamartoma tumor syndromes (PHTS) increase cancer risk. Individuals with germline PTEN mutations should follow CS cancer surveillance guidelines for early detection and management.

Area of Science:

  • Oncology
  • Genetics
  • Medical Syndromes

Background:

  • Cowden syndrome (CS) is a cancer predisposition syndrome linked to PTEN gene mutations.
  • PTEN mutations also cause Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome (PS), and Proteus-like syndrome (PSL).
  • These conditions fall under the umbrella of PTEN hamartoma tumor syndrome (PHTS), exhibiting overlapping yet distinct clinical features.

Purpose of the Study:

  • To highlight the importance of recognizing PTEN hamartoma tumor syndromes (PHTS) beyond Cowden syndrome.
  • To emphasize the need for vigilance in identifying and screening individuals with germline PTEN mutations for increased cancer risk.
  • To provide updated recommendations for cancer surveillance in individuals with PHTS.

Main Methods:

  • Review of existing literature on PTEN hamartoma tumor syndromes (PHTS).

Related Experiment Videos

  • Analysis of clinical manifestations and genetic links associated with PTEN mutations.
  • Comparison of cancer predisposition and surveillance guidelines across different PHTS.

    • Main Results:

    • Cowden syndrome is the only PHTS with a definitively documented cancer predisposition.
    • Significant phenotypic overlap exists within PHTS, despite clinical distinctions.
    • Germline PTEN mutations are associated with a spectrum of disorders, some not historically linked to malignancy.

    Conclusions:

    • All individuals with germline PTEN mutations should adhere to Cowden syndrome cancer surveillance recommendations as a precautionary measure.
    • Ongoing research into new cancer predisposition syndromes and their genetic underpinnings is crucial.
    • Oncologists and healthcare providers must remain vigilant in identifying and managing at-risk individuals.